Reimagining Dry Eye Management: Targeting Tear Function for Sustained Relief

EP. 1: Identification and Diagnosis of Dry Eye Disease
ByKendall E. Donaldson, MD,Cecelia Koetting, OD, FAAO, DipABO,Selina R. McGee, OD, FAAO,Karl Stonecipher, MD Donaldson introduces the panel and outlines the series’ focus on improving dry eye management through tear function optimization.

EP. 2: Understanding Tear Composition and Function in Dry Eye Disease
ByKendall E. Donaldson, MD,Cecelia Koetting, OD, FAAO, DipABO,Selina R. McGee, OD, FAAO,Karl Stonecipher, MD Donaldson introduces the panel and outlines the series’ focus on improving dry eye management through tear function optimization.

EP. 3: Treatment Selection in Dry Eye Disease
ByKendall E. Donaldson, MD,Cecelia Koetting, OD, FAAO, DipABO,Selina R. McGee, OD, FAAO,Karl Stonecipher, MD Experts explain how differentiating these subtypes guides treatment choices and outcomes.

EP. 4: Limitations of Current Dry Eye Therapies
ByKendall E. Donaldson, MD,Cecelia Koetting, OD, FAAO, DipABO,Selina R. McGee, OD, FAAO,Karl Stonecipher, MD The discussion explores how basal and reflex tears differ and why composition impacts sustained eye comfort.

EP. 5: Managing Unique Dry Eye Disease Subtypes in Patients
ByKendall E. Donaldson, MD,Cecelia Koetting, OD, FAAO, DipABO,Selina R. McGee, OD, FAAO,Karl Stonecipher, MD Panelists share how they tailor therapy based on patient characteristics, symptoms, and clinical findings.

EP. 6: Clinical Experience and Integration of New Dry Eye Disease Therapies in the Clinic
ByKendall E. Donaldson, MD,Cecelia Koetting, OD, FAAO, DipABO,Selina R. McGee, OD, FAAO,Karl Stonecipher, MD The panel addresses common patient frustrations and therapeutic limitations in today’s dry eye landscape.

EP. 7: The Role of TRPM8 Agonists in Dry Eye Disease
ByKendall E. Donaldson, MD,Cecelia Koetting, OD, FAAO, DipABO,Selina R. McGee, OD, FAAO,Karl Stonecipher, MD Experts highlight management nuances in patients with neuropathic pain, post–refractive surgery complications, or contact lens intolerance.

EP. 8: Advantages of Neurogenic Stimulation and Identifying Ideal Dry Eye Candidates for Acoltremon
ByKendall E. Donaldson, MD,Cecelia Koetting, OD, FAAO, DipABO,Selina R. McGee, OD, FAAO,Karl Stonecipher, MD Panelists discuss new DED treatments like Miebo and Vevye and how they integrate into treatment algorithms.